Onomichi General Hospital
In research, Onomichi General Hospital stands highest in Medicine (#10,059 of 10,443 worldwide) and Health Sciences (#11,694 of 11,982 worldwide), 2022–2025.
- World rank, 2022–2025
- #27,537 of 28,054 · #41,106 all time
- Rank in Japan
- #1,053 of 1,070
- Research works
- 385 ▲ 21% vs 2013–17
- Citations
- 3k 7.8 per fractional work
- Top-10% rate
- 5.9% record average 16.5%
- Open access
- 58% world 28%
What is Onomichi General Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #10,059 of 10,443 | 5.9% | 64 | #15804 | |
| Health SciencesDomain | #11,694 of 11,982 | 6.1% | 66 | #18731 |
Each strip is that field’s whole ranked pool, with the notch where Onomichi General Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.8×. Every wedge is a field page.
- Medicine 4.8×
- Dentistry 3.0×
- Immunology and Microbiology 0.7×
- Biochemistry, Genetics and Molecular Biology 0.5×
- Health Professions 0.2×
- Nursing 0.2×
- Economics, Econometrics and Finance 0.1×
- Psychology 0.1×
- Agricultural and Biological Sciences 0.1×
- Neuroscience 0.1×
- Engineering 0.1×
- Physics and Astronomy 0.1×
- Arts and Humanities 0.0×
- Computer Science 0.0×
Who are the top researchers at Onomichi General Hospital?
Ranked on the composite score, Shuji Yonehara, Keiji Hanada and Tomoyuki Abe lead among researchers whose main affiliation is Onomichi General Hospital.
- 1 Shuji Yonehara Japan · #629,681 worldwide 30 citations · 33 works
- 2 Keiji Hanada Japan · #869,537 worldwide 42 citations · 46 works
- 3 Tomoyuki Abe Japan · #1,050,068 worldwide 59 citations · 73 works
- 4 Hajime Amano Japan · #1,105,364 worldwide 14 citations · 24 works
- 5 Toshio Noriyuki Japan · #1,114,478 worldwide 9 citations · 23 works
- 6 Masahiro Nakahara Japan · #1,159,330 worldwide 12 citations · 45 works
- 7 Akihiko Oshita Japan · #1,289,072 worldwide 4 citations · 16 works
- 8 Takuya Yano Japan · #1,303,819 worldwide 8 citations · 22 works
- 9 Hiroyuki Moriyama Japan · #1,505,671 worldwide 8 citations · 28 works
Which keywords describe research at Onomichi General Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Epidemiology, Clinical Practice Guidelines, Neoadjuvant Therapy, Tumor Microenvironment, Prognostic Factors and Treatment.
- Metastatic Carcinomas
- Molecular Pathology
- Genetic Mutations
- Neoadjuvant Chemotherapy
- Lymph Node Dissection
- Complications
- Liver Cancer
- Radiofrequency Ablation
- Cholangiocarcinoma
- Endoscopic Resection
- Hepatocellular Carcinoma
- Molecular Profiling
- Survival Analysis
- Surgical Management
- Surgical Complications
- Pancreatic Cancer
- Treatment
- Tumor Microenvironment
- Clinical Practice Guidelines
- Epidemiology
- Chemotherapy
- Immunotherapy
- Neoadjuvant Therapy
- Prognostic Factors
- Diagnosis
- Gemcitabine
- Management
- Molecular Characterization
- Immunohistochemistry
- Gastric Cancer
- Adjuvant Therapy
- Breast Cancer
- Guidelines
- Survival
- Sorafenib
- Prognosis
- Metastasis
- Genetic Factors
- Prognostic Markers
- Lung Tumors
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy12▲ 24×14 topics
- Epidemiology11▲ 4.0×40 topics
- Immunotherapy9▲ 18×9 topics
- Clinical Practice Guidelines7▲ 18×10 topics
- Neoadjuvant Therapy7▲ 41×5 topics
- Tumor Microenvironment6▲ 20×6 topics
- Prognostic Factors6▲ 20×8 topics
- Treatment6▲ 7.1×14 topics
- Diagnosis6▲ 8.8×12 topics
- Pancreatic Cancer6▲ 73×2 topics
- Gemcitabine6▲ 109×1 topic
- Surgical Complications6▲ 97×1 topic
- Management5▲ 8.8×12 topics
- Surgical Management4▲ 14×12 topics
- Molecular Characterization4▲ 32×4 topics
- Survival Analysis4▲ 20×4 topics
- Immunohistochemistry4▲ 69×3 topics
- Molecular Profiling4▲ 51×3 topics
- Gastric Cancer3▲ 44×3 topics
- Hepatocellular Carcinoma3▲ 22×2 topics
- Adjuvant Therapy3▲ 33×2 topics
- Endoscopic Resection3▲ 42×2 topics
- Breast Cancer3▲ 17×5 topics
- Cholangiocarcinoma3▲ 49×2 topics
- Guidelines3▲ 8.3×9 topics
- Radiofrequency Ablation3▲ 37×2 topics
- Survival3▲ 29×3 topics
- Liver Cancer2▲ 66×1 topic
- Sorafenib2▲ 66×1 topic
- Complications2▲ 6.9×10 topics
- Prognosis2▲ 11×7 topics
- Lymph Node Dissection2▲ 56×1 topic
- Metastasis2▲ 9.5×7 topics
- Neoadjuvant Chemotherapy2▲ 40×1 topic
- Genetic Factors2▲ 47×2 topics
- Genetic Mutations2▲ 7.4×9 topics
- Prognostic Markers2▲ 29×3 topics
- Molecular Pathology2▲ 27×2 topics
- Lung Tumors2▲ 161×1 topic
- Metastatic Carcinomas2▲ 161×1 topic
Which research topics does Onomichi General Hospital publish most on?
By volume in 2022–2025: Pancreatic and Hepatic Oncology Research, Hepatocellular Carcinoma Treatment and Prognosis, Gastric Cancer Management and Outcomes and Metastasis and carcinoma case studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pancreatic and Hepatic Oncology Research Oncology 6 works
- 2 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 2 works
- 3 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 2 works
- 4 Metastasis and carcinoma case studies Pulmonary and Respiratory Medicine 2 works
- 5 Pancreatitis Pathology and Treatment Surgery 2 works
- 6 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 2 works
- 7 Multiple and Secondary Primary Cancers Epidemiology 2 works
- 8 Myasthenia Gravis and Thymoma Neurology 1 works
- 9 Gallbladder and Bile Duct Disorders Pulmonary and Respiratory Medicine 1 works
- 10 Cancer Diagnosis and Treatment Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Onomichi General Hospital's research output changed?
Output in 2018–2022 was 21% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.